These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 825500)
1. A comparison of the British Pharmacopoeia (1973) and United States Pharmacopeia (1975) methods for detecting pseudomonads. Hart A; Moore KE; Tall D J Appl Bacteriol; 1976 Oct; 41(2):235-42. PubMed ID: 825500 [No Abstract] [Full Text] [Related]
2. A further simplified procedure for the detection of Pseudomonas aeruginosa in contaminated aqueous substrata. Mossel DA; De Vor H; Eeelderink I J Appl Bacteriol; 1976 Oct; 41(2):307-9. PubMed ID: 825503 [No Abstract] [Full Text] [Related]
3. Contamination of cetrimide and other fluids with Pseudomonas pyocyanea. LOWBURY EJ Br J Ind Med; 1951 Jan; 8(1):22-5. PubMed ID: 14812077 [No Abstract] [Full Text] [Related]
4. [Culture media for sterility testing. Comparison of the regulations of the pharmacopoeia of the GDR with other pharmacopoeias]. Friedemann J Z Gesamte Hyg; 1980; 26(12):908-13. PubMed ID: 7234011 [No Abstract] [Full Text] [Related]
5. [Efficient scheme for identifying Pseudomonas aeruginosa in mass screenings of the environment]. Kalina GP Gig Sanit; 1983 Nov; (11):58-63. PubMed ID: 6418617 [No Abstract] [Full Text] [Related]
6. Pseudomonads and man. Noble WC; White PM Trans St Johns Hosp Dermatol Soc; 1969; 55(2):202-8. PubMed ID: 4984243 [No Abstract] [Full Text] [Related]
7. Evaluation of a new agar medium containing cetrimide, kanamycin and nalidixic acid for isolation and enhancement of pigment production of Pseudomonas aeruginosa in clinical samples. Kodaka H; Iwata M; Yumoto S; Kashitani F J Basic Microbiol; 2003; 43(5):407-13. PubMed ID: 12964184 [TBL] [Abstract][Full Text] [Related]
8. Competitive growth of Salmonella and Pseudomonads in tetrathionate enrichment broth. Gundstrup AS Health Lab Sci; 1974 Jan; 11(1):25-7. PubMed ID: 4202603 [No Abstract] [Full Text] [Related]
9. [Use of salts of quaternary ammonium base for creation of selective media for Pseudomonas aeruginosa]. Moroz AF; Afinogenov GE; Bekbergenov BM Lab Delo; 1976; (5):302-3. PubMed ID: 62092 [No Abstract] [Full Text] [Related]
10. Fluorescent pseudomonads--a residual component in the soil microflora? Rovira AD; Sands DC J Appl Bacteriol; 1971 Mar; 34(1):253-9. PubMed ID: 4935440 [No Abstract] [Full Text] [Related]
11. Multipurpose medium for use with Pseudomonas species. Rosenthal SL Appl Microbiol; 1973 Dec; 26(6):1013-4. PubMed ID: 4588189 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media. Fonseca K; MacDougall J; Pitt TL J Clin Pathol; 1986 Feb; 39(2):220-2. PubMed ID: 3081597 [TBL] [Abstract][Full Text] [Related]
13. Applicability of cetrimide, nitrofurantoin, TTC, and sodium arsenite to the isolation of marine pseudomonads. Noseworthy JE; Moskovits G Can J Microbiol; 1974 Jul; 20(7):1065-9. PubMed ID: 4600732 [No Abstract] [Full Text] [Related]
14. [The distribution of and methods for detecting Pseudomonas aeruginosa in mineral waters]. Zotova VI; Afanas'eva MI; Tishkova NIu; Dolkova NG; Solovatchenko NI Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (1):44-7. PubMed ID: 2139997 [TBL] [Abstract][Full Text] [Related]
15. Pseudomonads in human saliva. Sutter VL; Hurst V; Landucci AO J Dent Res; 1966; 45(6):1800-3. PubMed ID: 4959855 [No Abstract] [Full Text] [Related]
16. Comparison of four selective agars for the isolation of pseudomonads. Hart A; Kite PE Appl Environ Microbiol; 1977 May; 33(5):1209-14. PubMed ID: 879777 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of culture media for the isolation and enumeration of Pseudomonas aeruginosa. Drake CH Health Lab Sci; 1966 Jan; 3(1):10-9. PubMed ID: 4955447 [No Abstract] [Full Text] [Related]
18. Pseudomonas aeruginosa contamination of liquid antacids: a survey. Robinson EP J Pharm Sci; 1971 Apr; 60(4):604-5. PubMed ID: 5001880 [No Abstract] [Full Text] [Related]
19. [Comparison of the American Pharmacopoeia (U.S.P.XII) and. the German Pharmacopoeia (DA B.6) and the supplementary book to the German Pharmacopoeia (Erg.-B.6)]. VENTH E Suddeutsch Apoth Ztg; 1947 Jun; 87(6):129-34. PubMed ID: 20260585 [No Abstract] [Full Text] [Related]
20. [ON THE AGREEMENT OF THE ADVANTAGES OF PYROGEN ASSAY PROCEDURES OF THE BRITISH PHARMACOPOEIA 1958, RESPECTIVELY, BY THE AUSTRIAN PHARMACOPOEIA IX. 1960 AND THE U.S. PHARMACOPOEIA XVI. 1960]. SIMON S; VRABEL M Arch Int Pharmacodyn Ther; 1963 Nov; 146():134-44. PubMed ID: 14077703 [No Abstract] [Full Text] [Related] [Next] [New Search]